img
Nuclear targeting peptide-modified, DOX-loaded, PHBV nanoparticles enhance drug efficacy by targeting to Saos-2 cell nuclear membranes     
Yazarlar
Ayla Şahin
Dr. Öğr. Üyesi Gözde EKE ÇEVİK Dr. Öğr. Üyesi Gözde EKE ÇEVİK
Türkiye
Arda Büyüksungur
Ankara Üniversitesi, Türkiye
Vasıf Nejat Hasırcı
Acıbadem Mehmet Ali Aydınlar Üniversitesi, Türkiye
Nesrin Hasırcı
Yakın Doğu Üniversitesi, Türkiye
Özet
The aim of this study was to target nano sized (266 +/- 25nm diameter) poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) particles carrying Doxorubicin (DOX), an anticancer agent, to human osteosarcoma cells (Saos-2). A nuclear targeting molecule (Nuclear Localization Signal, NLS), a 17 a.a. peptide, was attached onto the doxorubicin loaded nanoparticles. NLS conjugated nanoparticles surrounded the cell nuclei, but did not penetrate them. Free doxorubicinand doxorubicin loadednanoparticles entered the cytoplasm and were evenly distributed within the cytoplasm. The localization of the NLS-targetedparticles around the nuclear membrane caused a significantly higher decrease in the cancer cell numbers due to apoptosis or necrosis than the untargeted and free doxorubicin formulations showing the importance of targeting the nanoparticles to the nuclear membrane in the treatment of cancer.
Anahtar Kelimeler
PHBV | biodegradable nanoparticles | nuclear drug delivery | doxorubicin | nuclear localization signal
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
Dergi ISSN 0920-5063
Dergi Tarandığı Indeksler SCI
Makale Dili Türkçe
Basım Tarihi 01-2018
Cilt No 29
Sayı 5
Sayfalar 507 / 519
Doi Numarası 10.1080/09205063.2018.1423812